Sedia Biosciences Corporation - Product Pipeline Market Research & Analysis 2015 Update

"The Report Sedia Biosciences Corporation - Product Pipeline Analysis, 2015 Update provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -"



Sedia Biosciences Corporation (SBC) is a privately held Delaware-registered medical device and diagnostics company. The company’s products include medical devices, diagnostic devices, HIV incidence products, rapid point of care assays, and specimen collection devices. It also provides innovative diagnostic products, epidemiological products, clinical products, rapid point of care diagnostic assays, novel epidemiological disease surveillance assays, monitoring devices, and other public health tools. SBC offers services such as technology licensing, commercialization, medical device manufacturing and distributing, diagnostic testing, monitoring, white labeling, and technology transfer and development services. The company has presence in Europe, Asia, and the Americas. SBC is headquartered in Portland, Oregon, the US.

View Full Report at:

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

Download Detail Report With Complete TOC at:

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Sedia Biosciences Corporation

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Categories: Medical Research, Market